STOCK TITAN

Korsana Biosciences officer plans 1,571-share sale

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
144

Rhea-AI Filing Summary

Korsana Biosciences, Inc. (KRSA) officer Rhonda Chicko reported a proposed sale of 1,571 common shares, with an aggregate market value of $60,876.25. The notice gives an approximate sale date of November 20, 2026. Chicko acquired the shares from the issuer through an exercise on August 14, 2026, with cash payment.

Shares proposed for sale 1,571 shares Korsana Biosciences common stock
Aggregate market value $60,876.25 Shares proposed for sale
Shares outstanding 45,541,358 shares Korsana Biosciences common stock

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many KRSA shares does officer Rhonda Chicko plan to sell?

The notice lists 1,571 common shares for sale, with an aggregate market value of $60,876.25 and an approximate sale date of November 20, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Keep reading